Health and Fitness Health and Fitness
Wed, October 6, 2010
[ Wed, Oct 06th 2010 ] - Market Wire
Life Technologies Sets 3rd Quarter 2010 Earnings Release Date for Tuesday, October 26, 2010
[ Wed, Oct 06th 2010 ] - Market Wire
Furiex Pharmaceuticals Announces Third Quarter 2010 Earnings Release, Webcast and Conference Call
[ Wed, Oct 06th 2010 ] - Market Wire
DaVita Inc. Announces Pricing of $1.55 Billion Senior Notes
[ Wed, Oct 06th 2010 ] - Market Wire
BELLUS HEALTH ANNOUNCES APPOINTMENT OF MARTIN TOLAR, M.D., Ph.D. TO ITS BOARD OF DIRECTORS
[ Wed, Oct 06th 2010 ] - Market Wire
Aetna Continues Efforts to Improve Access to Quality Care in the Middle East
[ Wed, Oct 06th 2010 ] - Market Wire
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 27, 2010
[ Wed, Oct 06th 2010 ] - Market Wire
Medtronic Announces New Curette for Treatment of Vertebral Compression Fractures
[ Wed, Oct 06th 2010 ] - Market Wire
Levi & Korsinsky, LLP Announces Class Action Laws .. Pharmaceuticals, Inc. and Its Board of Directors
Tue, October 5, 2010
[ Tue, Oct 05th 2010 ] - Market Wire
Medwell Capital announces management change
[ Tue, Oct 05th 2010 ] - Market Wire
Synergetics USA to Webcast Presentation at Craig-Hallum Capital Group 2010 Alpha Select Conference
[ Tue, Oct 05th 2010 ] - Market Wire
VARIAN MEDICAL SYSTEMS AND IMRIS TO CO-DEVELOP RE .. OLUTIONARY NEW MR-GUIDED RADIATION THERAPY SYSTEM
[ Tue, Oct 05th 2010 ] - Market Wire
The Briscoe Law Firm Investigates Johnson & Johns .. for Possible Breaches of Fiduciary Duties by its
[ Tue, Oct 05th 2010 ] - Market Wire
Apricus Bio Closes Securities Offering, Raising over $9.3 Million
[ Tue, Oct 05th 2010 ] - Market Wire
International Stem Cell Corporation and Insight B .. dian Affiliate to Develop Stem Cell-Based Eye Car
[ Tue, Oct 05th 2010 ] - Market Wire
In un importante studio la matrice tissutale rico .. ea" esibisce un elevato tasso di successo nel tra
[ Tue, Oct 05th 2010 ] - Market Wire
La matriz de tejido reconstructivo LifeCella" Str .. ndice de ©xito en el tratamiento de hernias vent
[ Tue, Oct 05th 2010 ] - Market Wire
LifeCella" Stratticea" Rekonstruktive Gewebematri .. ne hohe Erfolgsrate bei der Behandlung von komple
[ Tue, Oct 05th 2010 ] - Market Wire
LifeCell Strattice Reconstructive Tissue Matrix v .. complexe buikbreuken volgens belangrijk onderzoek
[ Tue, Oct 05th 2010 ] - Market Wire
Human Genome Sciences Receives Complete Response .. from FDA on ZALBINa" BLA for Chronic Hepatitis C
[ Tue, Oct 05th 2010 ] - Market Wire
RHUCIN Clinical Trial Data Published in the Journal of Allergy and Clinical Immunology
[ Tue, Oct 05th 2010 ] - Market Wire
Spectral Molecular Imaging Announces the Appointm .. President for International Business Development
[ Tue, Oct 05th 2010 ] - Market Wire
ImmunoCellular Therapeutics' Clinical Data for ICT-107 To Be Featured at World Stem Cell Summit
[ Tue, Oct 05th 2010 ] - Market Wire
Bond Labs Expands Retail Presence of Resurrectiona" in Minneapolis
[ Tue, Oct 05th 2010 ] - Market Wire
Celgene Prices $1.25 Billion of Senior Unsecured Notes
[ Tue, Oct 05th 2010 ] - Market Wire
Enzon Announces Publication of Preclinical Study Data of PEG-SN38 in Pediatric Neuroblastoma
[ Tue, Oct 05th 2010 ] - Market Wire
Philadelphia Eagles' Offensive Lineman Todd Herre .. ical to Endorse New SPO Wellness(TM) Product Line
[ Tue, Oct 05th 2010 ] - Market Wire
Orthovita Receives FDA Clearance for VITOMATRIXa" Bone Graft Substitute in Dental Applications
Mon, October 4, 2010
[ Mon, Oct 04th 2010 ] - Market Wire
The Briscoe Law Firm Investigates Baxter Internat .. eholders for Possible Breaches of Fiduciary Dutie
[ Mon, Oct 04th 2010 ] - Market Wire
Celera Announces Resignation of Chief Financial Officer
[ Mon, Oct 04th 2010 ] - Market Wire
Biogen Idec to Report Third Quarter 2010 Financial Results on October 26, 2010

Biogen Idec to Report Third Quarter 2010 Financial Results on October 26, 2010


Published on 2010-10-04 15:20:39 - Market Wire
  Print publication without navigation


WESTON, Mass.--([ BUSINESS WIRE ])--Biogen Idec Inc. (NASDAQ:BIIB) today announced it will report third quarter 2010 financial results on Tuesday, October 26, 2010, before the financial markets open.

Following the release of the financials, the Company will host a live webcast where Biogen Idec management will discuss the financial results, at 8:30 am ET. To access the live webcast please go to Biogen Ideca™s website at investor.biogenidec.com. Following the live webcast, an archived version of the call will be available at the same URL.

About Biogen Idec

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For product labeling, press releases and additional information about the company, please visit [ www.biogenidec.com ].

Contributing Sources